Radico Khaitan Ltd

Q1 FY25 Earnings Call Analysis

Beverages

Full Stock Analysis
revenue: Category 2margin: Category 2orderbook: No informationfundraise: No informationcapex: No
📊

revenue

Future growth expectations in sales/revenue/volumes?

- FY25 export volumes grew beyond FY24 record, now at ~5% of total business by volume and ~9% by value, continuing growth trend. - Regular segment expected to grow 12-13% in FY26. - Prestige & Above (P&A) segment projected to grow 15%+ in FY26. - Andhra Pradesh RTM policy changes boosted growth; expect continued strong growth in that market. - Overall volume growth achieved 28% in Q4 FY25, highest-ever quarterly volume. - Luxury portfolio (e.g., Royal Ranthambore, Single Malt, Jaisalmer Gin) showing strong month-on-month growth. - Focus on double-digit growth in Prestige & Above category long-term. - Capacity expansions sufficient for next 3-4 years; no immediate need for new CAPEX. - EBITDA margins expected to improve by ~100 basis points in FY26 with ongoing premiumization and portfolio growth.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Radico Khaitan expects a strong double-digit growth in the Prestige & Above (P&A) category, targeting 15%+ growth for FY26 and onwards. - Regular category volumes are expected to grow by 12%-13% in FY26. - EBITDA margins improved by 150 basis points in FY25 over FY24, with an anticipated 100 basis points improvement in FY26 due to brand portfolio growth and P&A expansion. - Management is optimistic about surpassing INR 500 crores revenue in the luxury portfolio, driven by strong growth in brands like Royal Ranthambore, Jaisalmer, and Rampur. - The business model is tuned for continuous margin improvement over the next 3 years, supported by premiumization and stable raw material prices. - Debt reduction is a priority, with a 35%-40% debt decrease expected in FY26, leading to near debt-free status by FY27, positively impacting profitability.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

The provided transcript from the earnings call does not explicitly mention details about the current or expected order book or pending orders. However, related insights include: - The company recently launched new products, including two luxury products in Q1 and a super-premium whisky targeting an 18 million cases market by H1. - The business is growing in key states like Telangana and Andhra Pradesh, with Telangana reported to have old outstanding dues below INR 100 crores, now being paid regularly. - Capacity expansions were made two years ago at the Sitapur unit, deemed sufficient for the next 3-4 years, implying no immediate need for further capex related to order fulfillment. - The company is confident in volume growth with regular category volumes expected to grow 12-13% and premium & above (P&A) categories growing 15%+. - No specific figures on order backlog or pending orders were disclosed.
💰

fundraise

Any current/future new fundraising through debt or equity?

- There is no mention of any current or planned new fundraising through debt or equity in the transcript. - The company is focused on reducing its existing debt and aims to be almost debt-free by FY27. - For FY26, the target is to reduce debt by around 35% to 40%, with complete repayment expected in about two years as per cash flow generation. - No plans for fresh debt or equity raising have been disclosed; the management appears confident in managing growth and operations with existing resources. - The Sitapur unit, one of the largest in Asia, provides sufficient capacity for the next 3 to 4 years, limiting the immediate need for additional capital expenditure or fundraising.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- No immediate plans for new CAPEX related to ENA capacity as the Sitapur unit, established about 2 years ago, is sufficient for the next 3-4 years. - Focus remains on expanding and upscaling product portfolio, including launches in super-premium whisky and luxury segments (two luxury products in Q1 and one super-premium whisky before H1 end). - Continuous innovation and market research to launch upscale products but no mention of large-scale capital investments currently. - The company is prioritizing distribution breadth and judicious brand launches over aggressive CAPEX. - Debt reduction is a focus with an aim to be nearly debt-free by FY27, implying prudent financial management rather than heavy capital spending in the near term.